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Background
Determining the sample size is a vital aspect of rando-
mised control trial design; typically a (target) difference is
specified. This provides reassurance that the study will be
informative; i.e. should such a difference exist, it is likely
to be detected with the required statistical precision. From
both a scientific and ethical standpoint, selecting an appro-
priate target difference is of crucial importance; too large
or small a study is arguable unethical, wasteful and poten-
tially misleading. While a variety of methods have been
proposed to specify a target difference, their relative merits
are unclear.
Aim
To review systematically medical and non-medical
literature to identify methods for specifying the target
difference in a randomised controlled trial.
Methods
Electronic searches of medical and non-medical data-
bases were performed. Clinical trial textbooks were also
reviewed. Titles and abstracts were screened prior to
full-text assessment. Studies that reported a method that
could be used to specify an important and/or realistic
difference were included.
Results
The search identified 11,485 potentially relevant studies;
1,434 were selected for full-text assessment. Seven
methods were identified: anchor, distribution, health
economic, opinion-seeking, pilot study, reviews of the
evidence base and standardised effect size (SES). The
anchor, distribution and SES methods were most com-
monly used.
Discussion
Seven methods, each with important variations in appli-
cation and different advantages and disadvantages are
available to inform specification of the target difference.
Their use can help ensure future trials will provide a
meaningful finding and be an efficient use of resources.
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